The Effectiveness of Probiotics for the Therapy of Acute Pharyngotonsillitis in Adult Patients
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01679366 |
Recruitment Status :
Completed
First Posted : September 6, 2012
Last Update Posted : October 22, 2014
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Throat Pain | Drug: Placebo Drug: Probiotics | Phase 3 |
Hypothesis The addition of probiotics to the routine therapy of AP in adult patients may shorten the duration, and reduce the severity of the disease.
Study design A prospective, randomized, placebo-controlled, double-blinded study comparing treatment with probiotics to placebo in patients with AP.
The study will be conducted in accordance with the ethical standards of the Helsinki Declaration and will be approved by the Human Experimentation Ethics Committee of the Ziv Medical Center. Signed informed consent will be required from all patients before inclusion.
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 57 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Double (Participant, Investigator) |
Primary Purpose: | Treatment |
Official Title: | The Effectiveness of Probiotics for the Therapy of Acute Pharyngotonsillitis in Adult Patients |
Study Start Date : | October 2012 |
Actual Primary Completion Date : | September 2013 |
Actual Study Completion Date : | October 2013 |
Arm | Intervention/treatment |
---|---|
No Intervention: Penicillin G
hospitalization of 30 patients given penicilline intraveniously for 72 hours
|
|
Placebo Comparator: Placebo
30 hospitalized patients will be given placebo with a regular penicillin treatment
|
Drug: Placebo
1 tablet 2 times daily
Other Name: Sugar pill for mimic probiotics |
Experimental: Probiotic
Probiotics will be given to 30 hospitalized patients with regular penicillin treatment
|
Drug: Probiotics
1 tablet twice daily
Other Name: BLIS |
- period of disease [ Time Frame: 10 days ]Patients will be followed daily while hospitalized. After discharge patients will fill a daily dairy for 10 days and record symptoms, signs, drinking, eating, and return to normal life. All dairies will be collected on day 10 of the study.
- analysis [ Time Frame: 10 days ]Follow-up throat culture, CBC, CRP, and ESR on day 4 of the study or at discharge if before. For patients with abnormal laboratory tests on admission, repeat tests are performed before discharge according to the routine of the department. For patients with normal tests on admission, these tests will be part of the study. For patients with Streptococcus pyogenes growth on admission and day 4 of the study, another throat culture will be done on day 10 of the study

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Age over 18 years
- Acute pharyngotonsillitis for which hospitalization for intravenous antibiotic treatment and/or fluids is needed
Exclusion Criteria:
- Current therapy with systemic prednisone or equivalent at 20 mg/d for more than 10 days prior to inclusion

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01679366
Israel | |
Ziv Medical Center | |
Safed, Israel |
Principal Investigator: | Leonid Livshits, MD | Ziv Medical Center |
Responsible Party: | Ziv Hospital |
ClinicalTrials.gov Identifier: | NCT01679366 |
Other Study ID Numbers: |
0054-11-ZIV |
First Posted: | September 6, 2012 Key Record Dates |
Last Update Posted: | October 22, 2014 |
Last Verified: | November 2011 |